Pancreatic Cancer Januvia Lawsuit

January 10, 2013

Januvia is a prescription medication used for the treatment of type-2 diabetes among adults. Research conducted by professionals at UCLA medical school determined that there may be a link between the use of Januvia and pancreatic and thyroid cancer. Januvia was approved for use in the United States by the Food and Drug Administration (FDA) in 2006.

In 2009, the Food and Drug Administration (FDA) issued a change to the warning for the label of Januvia which required the addition of more side effects information. These changes included adding pancreatic cancer and Januvia thyroid cancer. If you or a loved one has taken Januvia and developed pancreatic cancer, you are not alone. You may be entitled to financial compensation through a pancreatic cancer Januvia lawsuit.

Januvia was initially approved by the Food and Drug Administration (FDA) in late 2006. Between its 2006 introduction and 2009, the Food and Drug Administration (FDA) received 88 complaints of acute pancreatitis among those taking Januvia. Of those, more than 60 required hospitalization with 4 going to the ICU. Among these cases, the Food and Drug Administration (FDA) discovered that almost 20 of them occurred within 30 days of beginning Januvia. Further, half of the cases of acute pancreatitis subsided after ceasing the use of Januvia.

This research is especially important because pancreatitis is a leading risk factor for the development of pancreatic cancer. In many cases of pancreatic cancer, patients initially suffer from pancreatitis. The FDA has required Merck (the makers of Januvia) to include information on their warning label related to the reports of acute pancreatitis.

The new Januvia warning labels also recommend that medical professionals watch their patients closely for signs of developing pancreatitis and to cease the medication if these pancreatic cancer signs do occur. Further, Merck must include information related to the unknown qualities of Januvia and its potential for causing pancreatic cancer. They must include information stating that Januvia has not been thoroughly tested among individuals with a history of pancreatitis.

Pancreatic Cancer Januvia

If you or a loved one has taken Januvia for the treatment of Type 2 diabetes and has subsequently developed pancreatic cancer, you are not alone. You may be entitled to financial compensation from the manufacturers through a Januvia Pancreatic Cancer Lawsuit against the makers of the potentially harmful drug. There is reason to believe that the manufacturer knew or should have known about these potential Januvia pancreatic cancer risks. Please call one of our pharmaceutical liability lawyers today for a free consultation regarding your Januvia Lawsuit. All Januvia lawsuits are processed on a contingency fee basis, which means that you don’t pay anything unless your case is successful.